Table 1.
Baseline Characteristics.
| Characteristics | All participants |
Mindful walking |
Walking |
|---|---|---|---|
| n = 51 | n = 24 | n = 27 | |
| Mean ± SD/n (%) | Mean ± SD/n (%) | Mean ± SD/n (%) | |
| Age (years) | 55.8 ± 10.9 | 55.4 ± 13.0 | 56.2 ± 8.8 |
| Body Mass Index (kg/m²) | 25.2 ± 3.8 | 25.0 ± 3.4 | 25.4 ± 4.2 |
| Pre-/Perimenopausal | 15 (29.4) | 10 (41.7) | 5 (18.5) |
| Postmenopausal | 36 (70.6) | 14 (58.3) | 22 (81.5) |
| Time since the end of primary therapy (years) | 4.2 ± 4.6 | 3.5 ± 2.9 | 4.8 ± 5.8 |
| - median (years) | 2.5 | 2.7 | 1.9 |
| Radiotherapy | 41 (80.4) | 18 (75.0) | 23 (85.2) |
| Chemotherapy | 25 (49.0) | 12 (50.0) | 13 (48.2) |
| Antihormonal therapy | 37 (72.6) | 16 (66.7) | 21 (77.8) |
| Continuing | 31 (83.8) | 14 (87.5) | 17 (81.0) |
| Completed | 6 (16.2) | 2 (12.5) | 4 (19.1) |
| Antibody therapy | 8 (15.7) | 5 (20.8) | 3 (11.1) |
| Continuing | 2 (25.0) | 1 (20.0) | 1 (33.3) |
| Completed | 6 (75.0) | 4 (80.0) | 2 (66.7) |
| Persisting side-effects through therapy | 49 (96.1) | 23 (95.8) | 26 (96.3) |
| Functional capacity (%) | 65.5 ± 16.0 | 65.1 ± 14.9 | 65.8 ± 17.3 |
| Stress VAS (0-100 mm) | 67.0 ± 2.8 | 68.9 ± 13.7 | 65.3 ± 11.9 |
Values are shown as the absolute numbers (n) and percentages (%), means and standard deviations (SD) or medians.
Abbreviation: VAS, visual analog scale.